Bioelectric Medicine Market by Product (Cardiac Pacemakers, Cochlear Implants, Deep Brain Stimulators), Type (Implantable Electroceutical Devices, Noninvasive Electroceutical Devices), Indication, End-User - Global Forecast 2023-2030

Bioelectric Medicine Market by Product (Cardiac Pacemakers, Cochlear Implants, Deep Brain Stimulators), Type (Implantable Electroceutical Devices, Noninvasive Electroceutical Devices), Indication, End-User - Global Forecast 2023-2030


The Bioelectric Medicine Market is projected to reach USD 53.66 billion by 2030 from USD 21.25 billion in 2022, at a CAGR of 12.27% during the forecast period.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Bioelectric Medicine Market.
  • Based on Product, market is studied across Cardiac Pacemakers, Cochlear Implants, Deep Brain Stimulators, Implantable Cardioverter Defibrillators, Sacral Nerve Stimulators, Spinal Cord Stimulators, Transcutaneous Electrical Nerve Stimulators, and Vagus Nerve Stimulators. The Sacral Nerve Stimulators is projected to witness significant market share during forecast period.
  • Based on Type, market is studied across Implantable Electroceutical Devices and Noninvasive Electroceutical Devices. The Implantable Electroceutical Devices is projected to witness significant market share during forecast period.
  • Based on Indication, market is studied across Arrhythmia, Chronic Pain, Depression, Epilepsy, Parkinson’s Disease, Tremor, and Urinary & Fecal Incontinence. The Urinary & Fecal Incontinence is projected to witness significant market share during forecast period.
  • Based on End-User, market is studied across Hospitals and Pharmaceutical Research. The Hospitals is projected to witness significant market share during forecast period.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Bioelectric Medicine Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Bioelectric Medicine Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Bioelectric Medicine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, BioMed Central Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, CEFALY Technology sprl, ElectroCore, Inc., General Electric Company, LivaNova PLC, MED-EL Elektromedizinische Geräte Gesellschaft m.b.H., Medtronic PLC, NeuroSigma, Inc., Nevro Corp., Oticon Medical A/S by Cochlear Ltd, Renishaw PLC, ReShape Lifesciences, Inc., Siemens Healthineers AG, Sonova Holding AG, and Vomaris Innovations, Inc..

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the Bioelectric Medicine Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Bioelectric Medicine Market?
  3. What is the competitive strategic window for identifying opportunities in the Bioelectric Medicine Market?
  4. What are the latest technology trends and regulatory frameworks in the Bioelectric Medicine Market?
  5. What is the market share of the leading vendors in the Bioelectric Medicine Market?
  6. Which modes and strategic moves are suitable for entering the Bioelectric Medicine Market?


Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Bioelectric Medicine Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing frequency of chronic diseases among population
5.1.1.2. Growing infrastructure expenditure in healthcare sector in developing economies
5.1.1.3. Rising incidences of Parkinson’s disease in aging population
5.1.2. Restraints
5.1.2.1. High costs associated with manufacturing of bioelectric medical devices
5.1.3. Opportunities
5.1.3.1. Advanced innovations in development of novel bioelectric medicine
5.1.3.2. Rising rate of regulatory approval for bioelectric medicines
5.1.4. Challenges
5.1.4.1. Stern government rules and regulations for the development and production of medical devices
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Bioelectric Medicine Market, by Product
6.1. Introduction
6.2. Cardiac Pacemakers
6.3. Cochlear Implants
6.4. Deep Brain Stimulators
6.5. Implantable Cardioverter Defibrillators
6.6. Sacral Nerve Stimulators
6.7. Spinal Cord Stimulators
6.8. Transcutaneous Electrical Nerve Stimulators
6.9. Vagus Nerve Stimulators
7. Bioelectric Medicine Market, by Type
7.1. Introduction
7.2. Implantable Electroceutical Devices
7.3. Noninvasive Electroceutical Devices
8. Bioelectric Medicine Market, by Indication
8.1. Introduction
8.2. Arrhythmia
8.3. Chronic Pain
8.4. Depression
8.5. Epilepsy
8.6. Parkinson’s Disease
8.7. Tremor
8.8. Urinary & Fecal Incontinence
9. Bioelectric Medicine Market, by End-User
9.1. Introduction
9.2. Hospitals
9.3. Pharmaceutical Research
10. Americas Bioelectric Medicine Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Bioelectric Medicine Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Bioelectric Medicine Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Aleva Neurotherapeutics SA
14.1.3. BioMed Central Ltd.
14.1.4. Biotronik SE & Co. KG
14.1.5. Boston Scientific Corporation
14.1.6. CEFALY Technology sprl
14.1.7. ElectroCore, Inc.
14.1.8. General Electric Company
14.1.9. LivaNova PLC
14.1.10. MED-EL Elektromedizinische Geräte Gesellschaft m.b.H.
14.1.11. Medtronic PLC
14.1.12. NeuroSigma, Inc.
14.1.13. Nevro Corp.
14.1.14. Oticon Medical A/S by Cochlear Ltd
14.1.15. Renishaw PLC
14.1.16. ReShape Lifesciences, Inc.
14.1.17. Siemens Healthineers AG
14.1.18. Sonova Holding AG
14.1.19. Vomaris Innovations, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings